Advanced Lipid Testing
Refined Sugars and the Rise of Small LDL Particles
Refined sugars raise blood sugar, drive insulin resistance, and increase harmful small LDL particles. These dense cholesterol particles slip into artery walls, fueling heart risk. Even with normal cholesterol, patients may face hidden danger. Discover how advanced lipid testing and smarter diet choices uncover risks and lower cardiovascular burden for lasting health.
Published
A New Way to Lower Lipoprotein(a): What Patients Should Know
Lipoprotein(a), or Lp(a), is a cholesterol-like particle made in the liver. Unlike LDL or “bad” cholesterol, Lp(a) levels are mostly inherited. You can have high levels even with a healthy lifestyle. Researchers have now tested a new treatment called lepodisiran, an investigational small interfering RNA therapy. It’s designed to block the liver from making Lp(a). The results are promising.
Published
Why Do Some People With Very High Lipoprotein(a) Have Clean Arteries?
Lipoprotein(a), or Lp(a), has been a major focus in cardiovascular research for years. Elevated levels are strongly linked to increased risks of heart attacks, strokes, and atherosclerosis (plaque buildup in arteries). Yet, a paradox exists—some individuals with very high Lp(a) levels have clean coronary arteries and show no signs of cardiovascular disease (CVD).
Published
The Power of Advanced Lipid Testing & CAC
When it comes to heart health, cholesterol often steals the spotlight. But advanced lipid testing goes far beyond standard cholesterol checks, revealing a more detailed picture of cardiovascular risk. For anyone serious about proactive heart health, understanding these tests is a game changer.
Published
A Brief History of Lipoprotein(a)
Lipoprotein(a), or Lp(a), is one of the most intriguing molecules in cardiovascular research. Though less known than LDL or HDL cholesterol, its role in heart disease is undeniable. Understanding its history reveals how science has gradually unraveled its significance and potential for treatment.
Published
A Closer Look at the Complexity of Lipid Testing
For anyone who’s ever reviewed a lipid panel, terms like LDL, VLDL, IDL, Lp(a), non-HDL, TRP, Apo B, small-LDL, lipoprotein size, and particle number can feel overwhelming. Add obesity, insulin resistance, and metabolic syndrome, and it’s easy to see why many patients—and even clinicians—struggle to make sense of it all.
Published
Categorized as Heart Health, Hypertriglyceridemia, Insights from Dr. Tashko, Insulin Resistance, Lipid Health, Obesity Care
2024 NLA Expert Clinical Consensus on Apoprotein B (Apo B)
Here I summarize the National Lipid Association’s recent expert consensus, which emphasizes apolipoprotein B (Apo B) as a key tool in managing cardiovascular risk. Apo B, present on atherogenic lipoproteins, gives a more precise assessment of cardiovascular risk than traditional LDL cholesterol (LDL-C) measurements.
Published
Why Apo B Matters More Than Cholesterol for Atherosclerosis
ApoB, short for Apolipoprotein B, is becoming an essential tool in understanding and managing atherosclerosis. Traditional cholesterol tests tell us only part of the story about lipid health. ApoB provides a more complete picture by measuring the number of atherogenic, or “bad” particles that lead to heart disease.
Published
Atherosclerosis Made Simple
In the fast-paced world we live in, health can often feel like an afterthought—something we take for granted until a problem arises. But lurking beneath the surface, in the very arteries that sustain our lives, there can be a silent and dangerous condition: atherosclerosis.
Published
Small LDL Particles: The Hidden Menace to Your Heart and How to Measure Them
Small LDL particles are a critical factor in heart health that many people don’t know about. Because they’re small and dense, they can more easily penetrate your artery walls, causing plaque buildup and inflammation. High triglycerides often accompany small LDL particles, creating a dangerous combination that can increase your risk of cardiovascular disease.
Published
Categorized as Heart Health, Insights from Dr. Tashko, Insulin Resistance, Lipid Health, Triglycerides
Atherosclerosis: The Most Common Silent Threat
Imagine your arteries as vital highways, tirelessly transporting oxygen-rich blood to every corner of your body. Now, picture these highways gradually narrowing, obstructed by a buildup of plaque – a sticky, cholesterol-laden substance that threatens to impede the flow of life-sustaining blood. This is the insidious reality of atherosclerosis.
Published
Lp(a): The Hidden Risk Factor for Heart Disease You Need to Know About
Lp(a) is a significant, often underestimated risk factor for cardiovascular disease. Its unique characteristics, driven by the apo(a) protein, make it a potent contributor to atherosclerosis and related complications.
Published